No Data
No Data
Cordlife Group Receives Fifth SAC Capital Letter Amid Regulatory Challenges
Cordlife (SGX:P8A) received a fifth letter from SAC Capital on behalf of Nanjing Xinjiekou Department Store, according to a Tuesday filing on the Singapore Stock Exchange. The letter addresses recent
Cordlife Faces Extended Suspension of Cord Blood Operations in Singapore
Cordlife (SGX:P8A) was directed by the government to extend the suspension of its cord blood collection, testing, processing, and storage services for up to an additional three months from June 15, ac
Cordlife Ends Legal Battle Over Terminated Subscription Agreement
Cordlife (SGX:P8A) announced that the High Court of Singapore has permitted the withdrawal of an injunction application related to a subscription agreement, according to a Tuesday filing with the loca
Cordlife Swings to Net Loss in Q1 as Suspension Derails Operations
Cordlife (SGX:P8A) booked a net loss of SG$11.6 million in the first quarter, compared with a net profit of SG$1.2 million in the year-ago period, as the company struggled to achieve profitability aft
SG Morning Highlights | Cordlife Reports Net Loss of S$11.6 Million in Q1 2024 Due to Refunds
Stocks to watch: Cordlife, SIA.
Cordlife Posts Net Loss of $11.57 Mil for 1QFY2024 Due to Refund Fulfilment
No Data